|
BLMH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.54979983980309E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.12929995646994E-09 |
| Normal-vs-Stage2 |
3.411900E-02 |
| Normal-vs-Stage3 |
2.722300E-02 |
| Normal-vs-Stage4 |
2.615300E-04 |
| Stage1-vs-Stage2 |
1.519610E-01 |
| Stage1-vs-Stage3 |
3.017800E-01 |
| Stage1-vs-Stage4 |
9.660600E-01 |
| Stage2-vs-Stage3 |
6.956800E-01 |
| Stage2-vs-Stage4 |
2.474000E-01 |
| Stage3-vs-Stage4 |
5.783800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.41570002784886E-10 |
| Normal-vs-AfricanAmerican |
1.9841399999998E-05 |
| Normal-vs-Asian |
1.938390E-01 |
| Caucasian-vs-AfricanAmerican |
3.567600E-01 |
| Caucasian-vs-Asian |
7.163600E-01 |
| AfricanAmerican-vs-Asian |
5.928400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.5035000435264E-09 |
| Normal-vs-Female |
4.68149999877099E-08 |
| Male-vs-Female |
3.182200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.228700E-04 |
| Normal-vs-Extreme_Weight |
1.76770000004378E-06 |
| Normal-vs-Obese |
1.58603999999007E-05 |
| Normal-vs-Extreme_Obese |
4.203400E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.392240E-01 |
| Normal_Weight-vs-Obese |
2.833600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.333520E-02 |
| Extreme_Weight-vs-Obese |
7.011800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.232400E-01 |
| Obese-vs-Extreme_Obese |
1.017580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.212180E-02 |
| Normal-vs-Age(41-60Yrs) |
1.13340004048723E-10 |
| Normal-vs-Age(61-80Yrs) |
7.02210000036452E-07 |
| Normal-vs-Age(81-100Yrs) |
1.252370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.110400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.054400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.166990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.962500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.828200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.375600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.93178806284777E-14 |
| Normal-VS-Type2 PRCC |
2.555800E-02 |
| Normal-VS-KIRP CIMP |
7.524200E-01 |
| Normal-VS-Unclassified PRCC |
2.123500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.24419999969483E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.483620E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.671700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.055400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.047960E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.067620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.562400E-04 |
| Normal-vs-N1 |
2.198200E-02 |
| Normal-vs-N2 |
5.824000E-03 |
| N0-vs-N1 |
8.021200E-01 |
| N0-vs-N2 |
8.701000E-01 |
| N1-vs-N2 |
7.990400E-01 |
|
|
